- Home
- TLSI vs GRX Comparison
TLSI vs GRX Comparison
Compare TLSI & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSI | GRX |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 147.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | GRX |
|---|---|---|
| Price | $7.36 | $9.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.67 | N/A |
| AVG Volume (30 Days) | ★ 168.6K | 39.7K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.98% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $40,207,000.00 | N/A |
| Revenue This Year | $55.06 | N/A |
| Revenue Next Year | $46.04 | N/A |
| P/E Ratio | ★ N/A | $38.50 |
| Revenue Growth | ★ 49.52 | N/A |
| 52 Week Low | $3.42 | $7.73 |
| 52 Week High | $7.70 | $10.40 |
Technical Indicators
Market Signals| Indicator | TLSI | GRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.33 | 45.40 |
| Support Level | $6.06 | $9.51 |
| Resistance Level | $7.70 | $9.85 |
| Average True Range (ATR) | 0.63 | 0.14 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 84.65 | 17.59 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.